11VAC10-180-60. 약물 및 금지 물질.

A. 약물 및 금지 물질은 5개 등급으로 분류됩니다. 강좌는 다음과 같습니다:

1. Class 1. Substances found in this class have no generally accepted medical use in the racehorse and have a very high pharmacological potential for altering the performance of a racehorse. These substances should never be found in the horse's system through postrace testing or in the possession of any holder of a permit within the enclosure of a horse racing facility licensed by the commission. Such substances are potent stimulants of the nervous system including opiates, opium derivatives, synthetic opioids, psychoactive drugs, amphetamines and U.S. Drug Enforcement Agency (DEA) Scheduled I and II controlled substances.

2. Class 2. Substances in this class have a high potential to affect the outcome of a race. Most are not generally accepted as therapeutic agents in the racehorse. Many are products intended to alter consciousness or the psychic state of humans, and have no approved or indicated use in the horse. Some, such as injectable local anesthetics, have legitimate uses in equine medicine, but should not be found in a racehorse through postrace testing. The following groups of substances are in this class:

a. 아편 부분 작용제 또는 작용제-항작용제;

b. 비오피오이드 정신작용제(자극제, 진정제, 진통제 또는 신경이완제 효과를 가질 수 있는 약물);

c. 중추 신경계(CNS)에 자극 효과를 일으킬 수 있는 기타 물질;

d. 중추신경계 억제 작용이 두드러지는 약물;

e. 항우울제 및 항정신병 약물(중추신경계 자극 또는 억제 효과가 두드러지거나 그렇지 않은 경우를 포함하여);

f. 신경근육 차단 작용을 직접적으로 갖는 근육 차단 물질;

g. 신경 차단제로 사용될 가능성이 있는 국소 마취제(프로카인 제외);

h. 기타 생물학적 물질 및 뱀 독이나 신경 차단제로 사용될 수 있는 화학물질; 및

i. 에리트로포이에틴 (에포젠), 다르베포이에틴, 옥시글로빈, 헤모퓨어 또는 기타 혈액 도핑제.

3. Class 3. Substances found in this class may or may not have an accepted therapeutic use in the horse, but have a potential to enhance performance, and their presence in the horse's system is prohibited on race day. The following groups of substances are in this class:

a. 자율신경계에 영향을 미치는 물질로, 중추신경계(CNS)에 뚜렷한 영향을 미치지 않지만, 심혈관 및 호흡기계에 뚜렷한 영향을 미치는 물질(기관지 확장제는 이 범주에 포함됩니다);

b. 신경 차단 효과를 갖지만, 해당 물질의 마취 효과와 무관한 사용 방법에 의해 소변 잔류 농도가 높게 나타날 가능성이 있는 국소 마취제 (프로카인);

c. 경미한 진정 작용을 가진 기타 물질, 예를 들어 수면 유도 항히스타민제;

d. 주요 혈관 확장제/혈압 강하제;

e. 신장 기능과 체액 구성에 영향을 미치는 강력한 이뇨제; 및

f. 볼덴론, 스타노졸롤, 나드롤론 및 테스토스테론을 제외한 이 절의 다른 부분에 분류된 안드로겐성 및/또는 아나볼릭 스테로이드 및/또는 성장 호르몬.

4. 4. 이 분류에 속하는 물질은 주로 경주마에 일상적으로 사용되는 치료용 의약품입니다. 이들은 성능에 영향을 미칠 수 있지만, 일반적으로 그 영향력은 제한적입니다. 다음 약물 그룹이 이 분류에 속합니다:

a. 아편계 물질이 아닌 것으로, 경도의 중추성 진통 효과를 갖는 물질;

b. 자율신경계에 영향을 미치는 물질로, 중추신경계(CNS), 심혈관 또는 호흡기 시스템에 뚜렷한 영향을 미치지 않는 것:

(1) 단독으로 국소 혈관 수축제 또는 충혈 완화제로 사용되는 물질;

(2) 위장관 경련 완화제로 사용되는 물질;

(3) 방광을 비우는 데 사용되는 물질; 및

(4) 중추신경계 혈관이나 내장 기관의 평활근에 주요 영향을 미치는 물질.

(5) Antihistamines that do not have a significant CNS depressant effect (this does not include H1 blocking agents, which are listed in Class 5) 3).

c. 미네랄 코르티코이드 물질;

d. 골격근 이완제;

e. 항염증 작용으로 인해 통증을 완화할 수 있는 항염증 물질로, 다음과 같은 것이 포함됩니다:

(1) 비스테로이드성 항염증제 (NSAIDs);

(2) 코르티코스테로이드 (글루코코르티코이드); 및

(3) 다양한 항염증제.

f. 볼덴론, 스탠조졸, 나드롤론 및 테스토스테론은 각각 단독으로 투여되나, 조합하여 투여되지 않아야 하며, 11VAC10-180-75 에 명시된 수준에 따라 투여되어야 합니다.

예: 약한 이뇨제;

h. 심장 글리코시드 및 항부정맥제(이하 포함):

(1) 심장 글리코시드;

(2) 부정맥 치료제 (리도카인, 브레틸륨 및 프로프라놀롤을 제외함); 및

(3) 기타 심장 강장제.

i. 주사제 형태로 공급되지 않는 국소 마취제;

j. 설사 억제제; 및

k. 기타 물질(이하 포함):

(1) 약리학적 작용이 거의 없거나 전혀 없는 거담제;

(2) 위장약; 및

(3) 점액 용해제.

5. 5. 이 분류에 속하는 약물은 치료 목적으로 사용되는 약물로, 농도 한도가 설정되어 있으며 특정 기타 약제도 포함됩니다. 특히 포함되는 것은 매우 국소적인 작용만을 하는 약제들로, 예를 들어 위궤양 치료제와 특정 항알레르기 약제가 있습니다. 항응고제 약물도 포함됩니다.

B. 징계 조치.

1. 약물 및 의약품 위반으로 유죄 판결을 받은 개인에 대한 처벌을 부과할 때, 경주마의 치료를 위해 일상적으로 사용되는 치료용 의약품의 검출과 경주 당일 검사 샘플에서 어떤 농도에서도 존재할 이유가 없는 약물 사이에는 규제상의 구분이 이루어져야 합니다.

2. The stewards or the commission will may use the Racing Medication and Testing Consortium's penalty category and schedule most recent revision of the Association of Racing Commissioners International (RCI) Uniform Classification Guidelines for Foreign Substances as a starting place the guideline in the penalty stage of the deliberations for a rule violation for any drug listed in the Association of Racing Commissioners International (RCI) Uniform Classification Guidelines for Foreign Substances, revised July 2007 prohibited substance.

3. If a licensed veterinarian is administering or prescribing a drug not listed in the RCI Uniform Classification Guidelines for Foreign Substances or shown in the RMTC penalty guideline listing, the identity of the drug shall be forwarded to the commission veterinarian to be forwarded to the Racing Medication and Testing Consortium RCI for classification.

4. Any drug or metabolite thereof found to be present in a pre- pre-race or postrace sample that is not classified in the most current recent RCI Uniform Classification Guidelines for Foreign Substances shall may be assumed to be an RCI Class 1 Drug and the trainer and owner shall may be subject to those penalties as set forth in schedule "A" unless satisfactorily demonstrated otherwise by the Racing Medication and Testing Consortium, with a penalty category assigned.

5. The penalty categories and their related schedules, if applicable, shall be on the following criteria:

a. Whether the drug is approved by the U.S. Food and Drug Administration for use in the horse;

b. Whether the drug is approved by the U.S. Food and Drug Administration for use in any species;

c. Whether the drug has any legitimate therapeutic application in the equine athlete;

d. Whether the drug was identified as "necessary" by the RMTC Veterinary Advisory Committee;

e. Whether legitimate, recognized therapeutic alternatives exist; and

f. The current RCI classification of the drug.

6. Except as may be expressly stipulated in the regulations elsewhere, the penalty categories "A," "B," "C," and "D" and their related schedules for trainers and owners are as follows:

a. The recommended penalties for violations due to the presence of a substance carrying a category "A" penalty and for violations of 11VAC10-180-35 are:

(1) First offense for the trainer will be:

(a) Minimum one-year suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a five-year suspension;

(b) Minimum fine of $10,000 absent mitigating circumstances; and

(c) May be referred to the commission for any further action deemed necessary by the commission.

(2) Second lifetime offense in any jurisdiction for the trainer will be:

(a) Minimum five-year suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of license revocation with no reapplication for a five-year period;

(b) Minimum fine of $10,000 absent mitigating circumstances; and

(c) May be referred to the commission for any further action deemed necessary by the commission.

(3) Third and any subsequent lifetime offense in any jurisdiction for the trainer will be:

(a) Minimum 10-year suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of license revocation with no reapplication for a five-year period;

(b) Minimum fine of $10,000 absent mitigating circumstances; and

(c) May be referred to the commission for any further action deemed necessary by the commission.

(4) First offense for the owner will be:

(a) Disqualification and loss of purse; and

(b) Horse shall be placed on the veterinarian's list for 90 days and must pass a commission-approved examination before becoming eligible to be entered.

(5) Second lifetime offense in owner's stable in any jurisdiction will be:

(a) Disqualification, loss of purse and $5,000 fine; and

(b) Horse shall be placed on the veterinarian's list for 120 days and must pass a commission-approved examination before becoming eligible to be entered.

(6) Third and any subsequent lifetime offense in the owner's stable in any jurisdiction will be:

(a) Disqualification, loss of purse, $10,000 fine and 90 days suspension; and

(b) Horse shall be placed on the veterinarian's list for 180 days and must pass a commission-approved examination before becoming eligible to be entered.

b. The recommended penalties for violations due to the presence of a substance carrying a category "B" penalty, for the presence of more than one NSAID in a plasma or serum sample, and for violations of the established level for total carbon dioxide are:

(1) First offense for the trainer will be:

(a) Minimum 15-day suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a 60-day suspension; and

(b) Minimum fine of $2,500 absent mitigating circumstances. The presence of aggravating factors could be sued to impose a maximum fine of $10,000.

(2) Second offense within a 365-day period in any jurisdiction for the trainer will be:

(a) Minimum 30-day suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a 180-day suspension; and

(b) Minimum fine of $5,000 absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum fine of $10,000.

(3) Third and any subsequent offense within a 365-day period in any jurisdiction for the trainer will be:

(a) Minimum 90-day suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose up to a maximum of a two-year suspension;

(b) Minimum fine of $10,000 absent mitigating circumstances; and

(c) May be referred to the commission for any further action deemed necessary by the commission.

(4) First offense for the owner will be:

(a) Disqualification and loss of purse; and

(b) Horse must pass a commission-approved examination before becoming eligible to be entered.

(5) Second offense in the owner's stable within a 365-day period in any jurisdiction will be:

(a) Disqualification and loss of purse; and

(b) Horse must pass a commission-approved examination before becoming eligible to be entered.

(6) Third and any subsequent offense in owner's stable within a 365-day period in any jurisdiction will be:

(a) Disqualification and loss of purse;

(b) Minimum fine of $5,000 absent mitigating circumstances; and

(c) Horse shall be placed on the veterinarian's list for 45 days and must pass a commission-approved examination before becoming eligible to be entered.

c. The recommended penalties for violations due to the presence of a substance carrying a category "C" penalty are:

(1) First offense for the trainer will be:

(a) Disqualification and loss of purse; and

(b) Minimum fine of $500 absent mitigating circumstances.

(2) Second offense for the trainer within a 365-day period in any jurisdiction will be:

(a) Disqualification and loss of purse;

(b) Minimum fine of $1,000 absent mitigating circumstances; and

(c) Minimum 15-day suspension absent mitigating circumstances.

(3) Third and any subsequent offense for the trainer within a 365-day period in any jurisdiction will be:

(a) Disqualification and loss of purse;

(b) Minimum fine of $2,500 absent mitigating circumstances; and

(c) Minimum 30-day suspension absent mitigating circumstances.

(4) First offense for the owner will be:

(a) Disqualification and loss of purse;

(b) Horse must pass a commission-approved examination before becoming eligible to be entered.

(5) Second offense in owner's stable within a 365-day period in any jurisdiction will be:

(a) Disqualification and loss of purse;

(b) Horse shall be placed on the veterinarian's list for 45 days and must pass a commission-approved examination before becoming eligible to be entered.

(6) Third and any subsequent offense in owner's stable within a 365-day period in any jurisdiction will be:

(a) Disqualification and loss of purse;

(b) Minimum fine of $5,000 absent mitigating circumstances; and

(c) Horse shall be placed on the veterinarian's list for 60 days and must pass a commission-approved examination before becoming eligible to be entered.

d. The recommended penalty for violations due to the presence of a substance carrying a category "D" penalty is an official letter of reprimand.

7 . 5. Any permit holder of the commission, including practicing veterinarians, found to be responsible for the improper or intentional administration of any drug resulting in a positive test may be subject to the same penalties set forth to the trainer.

8 . 6. Any veterinarian found to be involved in the administration of any drug carrying the penalty category of "A" shall be referred to the respective state licensing board of veterinary medicine for consideration of further disciplinary action and/or license revocation. This is in addition to any penalties issued by the stewards or the commission.

9 . 7. Any person who the stewards or the commission believe may have committed acts in violation of criminal statutes shall be referred to the appropriate law-enforcement agency. Administrative action taken by the stewards or the commission in no way prohibits a prosecution for criminal acts committed, nor does a potential criminal prosecution stall administrative action by the stewards or the commission.

10 . 8. Pursuant to 11VAC10-60-70 E of the commission regulations, all horses in the care of a trainer who is suspended for more than 10 days must be transferred to another trainer approved by the stewards. During the period of suspension the suspended trainer shall have no communication with the new trainer, the new trainers' staff, or the horse owner; shall not benefit financially from transferred horses in his stable during the time of suspension; and shall not be permitted on the grounds except with the permission of the stewards.

11VAC10-180-70. 페닐부타존, 플루니신 및 기타 NSAID.

A. 일반적으로. 이 규정에 따라 버지니아 경마 위원회는 이 장에 규정된 양만큼 경주마에 페닐부타존 또는 플루닉신(동시 사용 불가)을 사용할 수 있도록 특별히 허용합니다.

B. 정량적 테스트. 페닐부타존 또는 플루닉신을 투여한 모든 말은 위원회 수의사의 지시에 따라 페닐부타존과 플루닉신의 정량적 수준 또는 존재할 수 있는 다른 물질의 존재 여부를 확인하기 위한 검사를 받아야 합니다.

C. Disciplinary actions. The stewards shall may take the following disciplinary actions for reports of quantitative testing by the primary testing laboratory for levels of phenylbutazone quantified at levels above 2.0 micrograms per milliliter of plasma or flunixin quantified at levels above 20 ng per milliliter of plasma in horses following races, qualifying races, and official timed workouts for the stewards or commission veterinarian:, and may use the most recent revision of the Association of Racing Commissioners International (RCI) Uniform Classification Guidelines for Foreign Substances as a guide. The stewards, in their discretion, may impose other more stringent disciplinary actions against trainers or other permit holders who violate the provisions under which phenylbutazone or flunixin is permitted by the commission.

1. The stewards shall impose the following for a post-race test quantifying flunixin above 20 ng per milliliter of plasma:

a. First offense within a 365-day period in any jurisdiction: $500 fine, disqualification and loss of purse;

b. Second offense within a 365-day period in any jurisdiction: $1,500 fine, disqualification and loss of purse; and

c. Third offense within a 365-day period in any jurisdiction: $2,500 fine, disqualification and loss of purse.

2. The stewards shall impose the following for a post-race test quantifying phenylbutazone above 2.0 micrograms per milliliter of plasma:

a. For levels of phenylbutazone quantified above 2.0 to below 2.6 micrograms per milliliter of plasma: a verbal warning;

b. For levels of phenylbutazone quantified from 2.6 to 5.0 micrograms per milliliter of plasma, first offense within a 365-day period in any jurisdiction: $500 fine;

c. For levels of phenylbutazone quantified from 2.6 to 5.0 micrograms per milliliter of plasma, second offense within a 365-day period in any jurisdiction: $500 fine, disqualification, and loss of purse;

d. For levels of phenylbutazone quantified from 2.6 to 5.0 micrograms per milliliter of plasma, third offense within a 365-day period in any jurisdiction: $1,500 fine, disqualification and loss of purse, and 15-day suspension;

e. For levels of phenylbutazone quantified above 5.0 micrograms per milliliter of plasma, first offense within a 365-day period in any jurisdiction: $1,500 fine, disqualification, and loss of purse:

f. Any subsequent offense for levels of phenylbutazone quantified above 5.0 micrograms per milliliter of plasma within a 365-day period in any jurisdiction: $2,500 fine, disqualification and loss of purse, and 15-day suspension.

3. The stewards, in their discretion, may impose other more stringent disciplinary actions against trainers or other permit holders who violate the provisions under which phenylbutazone or flunixin is permitted by the commission.

11VAC10-180-75. 안드로겐 및 단백 동화 스테로이드.

A. 아래에 명시된 경우를 제외하고 모든 남성호르몬 및 단백 동화 스테로이드는 경주마에게 금지됩니다.

B. 경주마에서 채취한 시험 샘플에서 아래 표시된 임계치 미만의 농도로 스타노졸롤, 난드롤론, 볼데논 및 테스토스테론의 주요 대사 산물의 잔류가 허용됩니다.

C. 이 섹션의 하위 섹션 B에서 확인된 이러한 물질의 농도는 다음의 총 임계 농도(즉, 유리 약물 또는 대사산물과 그 접합체에서 유리된 약물 또는 대사산물)를 초과하지 않아야 합니다:

1. Metabolite of stanozolol (16Beta-hydroxystanozolol) – 25 pg/ml in plasma or 1 ng/ml in urine for all horses regardless of gender.

2. Boldenone – 200 pg/ml in plasma or 15 ng/ml in urine in male horses other than geldings. No boldenone is permitted in geldings or female horses.

3. 난드롤론:

a. 50 pg/ml in plasma or 1 ng/ml in urine in geldings, fillies, and mares.

b. 50 pg/ml in plasma or 45 ng/ml in urine in male horses other than geldings.

c. 암말 이외의 수말은 검사 대상에서 제외됩니다.

4. 테스토스테론.

a. 25 pg/ml in plasma or 20 ng/ml in urine in geldings.

b. 25 pg/ml in plasma or 55 ng/ml in urine in fillies and mares.

c. 암말 이외의 수말은 검사 대상에서 제외됩니다.

D. 이 섹션의 하위 섹션 B에 명시된 네 가지 물질 중 하나 이상이 이 섹션의 하위 섹션 C에 명시된 개별 기준치보다 높은 농도로 존재하거나 안드로겐 또는 단백 동화 작용으로 인정된 두 가지 이상의 물질을 조합하여 사용하는 것은 금지됩니다.

E. 암말이 아닌 수말에서 채취한 시험 샘플은 반드시 실험실로 보내야 합니다.

F. 질병 또는 부상 회복을 돕기 위해 안드로겐 또는 단백 동화 스테로이드를 투여한 말은 소변 내 약물 또는 대사 산물의 농도를 모니터링하기 위해 수의사 목록에 등재될 수 있습니다. 농도가 지정된 기준치 이하로 떨어지면 해당 말은 목록에서 삭제될 수 있습니다.

G. The stewards shall may take disciplinary actions for reports of quantitative testing by the primary testing laboratory indicating the presence of one or more androgenic or anabolic steroid at concentrations above the individual thresholds indicated in subsection C of this section and may use the most recent revision of the Association of Racing Commissioners International (RCI) Uniform Classification Guidelines for Foreign Substances as a guide.

1. For the first violation of the regulation pertaining to androgenic and anabolic steroids regarding a particular horse, absent mitigating factors, the recommended penalties are:

a. Disqualification and loss of purse;

b. Fine up to $1,000 at the stewards' discretion if aggravating factors are found; and

c. The horse shall be placed on the veterinarian's list until the concentration has fallen below the designated threshold level.

2. For the second violation of the regulation pertaining to androgenic and anabolic steroids in a 365-day period for the same horse, absent mitigating factors, the recommended penalties are:

a. Disqualification and loss of purse;

b. Fine of $2,500, 90 days suspension; and

c. The horse shall be placed on the veterinarian's list until the concentration has fallen below the designated threshold level.

3. For the third violation of the regulation pertaining to androgenic and anabolic steroids in a 365-day period for the same horse, absent mitigating factors, the recommended penalties are:

a. Disqualification and loss of purse;

b. Revocation of permit; and

c. The horse shall be placed on the veterinarian's list until the concentration has fallen below the designated threshold level.

11VAC10-180-110. 실험실 검사 결과 및 보고서.

A. Primary testing laboratory. The commission shall designate a primary testing laboratory for the analysis of test samples collected under the supervision of the commission veterinarian. The commission shall designate a chief racing chemist within the primary testing laboratory who shall have the authority to report his findings to the executive secretary of the commission, the stewards and the commission veterinarian.

B. 참고 실험실. 위원회는 주요 시험실험실 이외의 하나 이상의 실험실을 참조 실험실로 지정하여야 한다. 이 실험실들은 분할 시료에 대한 확인 분석을 수행할 것입니다. 모든 참조 실험실은 확인 검사를 위해 분할 시료를 수락할 의향이 있어야 합니다. 모든 참조 실험실은 검사 결과를 검사 요청자와 위원회 양측에 모두 송부하여야 합니다.

C. Chief racing chemist's responsibilities. The chief racing chemist shall be responsible for safeguarding and analyzing the test samples delivered to the primary testing laboratory. It shall be the chief racing chemist's responsibility to maintain proper equipment, adequate staffing and acceptable procedures to thoroughly and accurately analyze test samples submitted to the primary testing laboratory.

D. 보고 절차. 주요 경주 화학자는 각 분석된 시험 시료에 대해 위원회 수의사에게 서면 보고서를 제출해야 하며, 시험 시료가 음성인지 또는 화학 성분 식별이 이루어졌는지 식별 태그 번호로 표시해야 합니다. 모든 확인된 양성 판정 결과는 집행 비서, 감독관 및 위원회 수의사에게 제출되어야 합니다.

E. Chemical identifications. If the chief racing chemist determines that there is present in the test sample a substance or metabolites of a substance foreign to the natural horse, except those specifically permitted by the regulations of the commission, he shall submit a report of chemical identification to the executive secretary of the commission, the stewards and the commission veterinarian. In a report of chemical identification, the chief racing chemist shall submit evidence acceptable in the scientific community and admissible in court in support of his determination.

F. Review of chemical identifications. Upon receipt of a report of a chemical identification from the chief racing chemist, the stewards shall conduct a review of the chemical identification, which shall include, but not be limited to, the chief racing chemist and the commission veterinarian. During the review, the following procedures shall apply:

1. 화학물질 식별 보고서에 대한 모든 인용은 해당 말로부터 채취된 시료의 식별 태그 번호로만 이루어져야 합니다.

2. 주요 경주 화학자는 화학 성분 분석 결과 및 해당 결론의 근거를 담은 서면 보고서를 제출하여야 한다;

3. The commission veterinarian shall submit a written statement to the stewards including, but not limited to, the class of the substance, the concentration level detected in the sample, if determined, and its probable effect on a racehorse;

4. 감시원은 언제든지 질문을 할 수 있으며, 필요하다고 판단할 경우 추가 서류를 요청할 수 있습니다;

5. 식별된 물질에 대한 적절한 정보를 받은 후, 감독관은 해당 화학물질의 식별 결과가 위원회 규정을 위반하는지 여부와 이를 양성 검사 결과로 간주해야 하는지 여부를 결정해야 합니다. 이를 수행할 때, 심판관들은 보고된 농도 수준, 해당 농도가 말에 미칠 가능성이 있는 영향, 그리고 환경 오염이 검사 결과에 기여했을 가능성 등을 고려해야 합니다.

6. In the event of a positive test result, the stewards shall notify the trainer and the owner of the horse of the right to send the split sample collected from the horse to one of the reference laboratories, designated by the commission, for confirmatory testing;

7. If the trainer or the owner elects to send the split sample to a reference laboratory, the stewards shall take no disciplinary action against any permit holder until the results from the reference laboratory are received, and the findings shall be a part of the record of any subsequent hearing; and

8. The chief racing chemist's report of a chemical identification, the commission veterinarian's written statement, the results of confirmatory testing and any other documentation submitted to the stewards shall become part of the record of any subsequent proceedings.

G. Barred from racing. No A horse from which a positive test sample was collected shall be permitted to race may be placed on the steward's list until the stewards have made a final determination in the matter. Such a The horse shall not be immune from resulting disciplinary action by the stewards or the commission.

H. Frozen samples. Unconsumed portions of all test samples tested by the primary testing laboratory will be maintained in a frozen state until cleared by the chief racing chemist and permission for their disposal is obtained from the Senior Commonwealth Steward.

I. 시료를 분할합니다. 위원회 수의사 또는 그 지정자는 주요 검사 실험실에 대한 최소 검사 샘플 요건을 결정합니다. 시험 시료가 최소 요구량 미달인 경우, 해당 시험 시료 전체를 주요 실험실로 송부하여야 합니다.

채취된 시료가 최소 시료 요구량보다 크지만 그 양의 두 배 미만인 경우, 최소 시험 시료 요구량을 초과하는 시험 시료의 부분은 분할 시료로 확보되어야 합니다.

시험 시료가 최소 시험 시료 요구량의 두 배를 초과하는 경우, 주요 시험 실험실로 배송된 시험 시료와 대략 동일한 양의 시료를 분할 시료로 확보해야 합니다.

J. Storage of split samples. Split samples shall be stored in secured location inside a locked freezer in accordance with the following procedures:

1. Split samples shall be secured in the test barn in the same manner as the portion of the test sample acquired for shipment to the primary laboratory until such time as test samples are packed and secured for shipment to the primary laboratory.

2. Upon packing of the test samples for shipment to the primary laboratory, the split samples shall be transferred to the locked freezer by the commission veterinarian or his authorized designee who shall be responsible for securing possession of the keys.

3. The freezer for storage of split samples shall be opened only for depositing or removing split samples, for inventory, or for checking the condition of split samples.

4. Whenever the freezer used for storage of split samples is opened, it shall be attended by the commission veterinarian or his designee and a representative of the horsemen if the respective horsemen's association has provided a representative. In the case that the split samples from a race must be secured in the freezer and no horsemen's representative is present, the commission veterinarian or his designee shall be in attendance.

5. A log shall be maintained each time the freezer used for storage of split samples is opened to specify each person in attendance, the purpose for opening the freezer, identification of split samples deposited or removed, the date and time the freezer was opened, and the time the freezer was locked.

6. Any evidence of a malfunction of the freezer used for storage of split samples or evidence that split samples are not in a frozen condition shall be documented in the log and immediately reported to the stewards.

K. Shipment of split samples. The trainer or owner of the horse shall have 48 hours from receipt of notice of a positive test result to request that the split sample be shipped to one of the reference laboratories designated by the commission and the split sample shall be shipped to the requested reference laboratory. The cost of shipment and additional testing shall be paid by the permit holder requesting the testing of the split sample. Upon the expiration of this 48-hour period, the trainer or owner relinquishes his right to request a split sample.

L. Chain of custody form. The commission veterinarian, or his designee, shall be responsible for the completion of a chain of custody verification form that shall provide a place for recording the following information:

1. Date and time the split sample is removed from the freezer;

2. The test sample number;

3. The address of the reference laboratory;

4. The name and address where the split sample package is to be taken for shipment to the reference laboratory;

5. Verification of retrieval of the split sample from the freezer;

6. Verification that each specific step of the split sample packaging procedure is in accordance with the recommended procedure;

7. Verification of the address of the reference laboratory on the split sample package;

8. Verification of the condition of the split sample package immediately prior to the transfer of custody to the carrier for shipment to the reference laboratory; and

9. The date and time custody of the split sample package was transferred to the carrier. The commission veterinarian, or his designee, shall witness, attest and sign the form, and a copy of the form shall be supplied to the trainer or owner.

In the event that the trainer or owner of the horse, or his designee, is not present, the commission veterinarian may not remove the split sample from the freezer or ship the split sample to a reference laboratory unless the trainer or owner has declined in writing his option to witness the removal, packaging and shipping procedure.

M. Packaging the split sample. The following procedures shall apply to the packaging of the split sample:

1. The split sample shall be removed from the freezer by the commission veterinarian or his designee; the trainer or owner, or his designee, may be present.

2. The trainer or owner, or his designee, may witness the packaging of the split sample by the commission veterinarian or his designee, in accordance with the instructions supplied by the reference laboratory.

3. The exterior of the package shall be secured and identified with initialed tape, evidence tape or other means to prevent tampering with the package.

4. The trainer or owner, or his designee, may accompany the commission veterinarian or his designee while delivering the package containing the split sample to the location where custody is transferred to the delivery carrier for shipment to the reference laboratory.

5. The trainer or owner, or his designee, may inspect the package containing the split sample immediately prior to transfer to the delivery carrier to verify that the package is intact and has not been tampered with.

6. The trainer or owner, or his designee, if witnessing the procedures, shall sign the chain of custody verification form.

양식 (11vac10-180)

Universal Bleeder Certificate - Examination for Exercise Induced Pulmonary Hemorrhage (eff. 3/98).

Furosemide Administration Report (eff. 3/98).

Chain of Custody Form (eff. 3/98).

Test Barn Daily Log (eff. 3/98).

Certification of Removal from the Lasix Program (eff. 7/00).

Schedule of Split Samples (Id) (eff. 7/00).

Test Barn Freezer Log (eff. 7/00).

Universal Bleeder Certificate - Examination Report for Excercise Induced Pulmonary Hemorrhage (eff. 9/09).

Chain of Custody Form (eff. 2/10).

Test Barn Daily Log (eff. 2/10).

Request to Remove Horse from the Furosemide Program (eff. 9/09).

Test Barn Samples Log (eff. 2/10).

Test Barn Freezer Log (eff. 2/10).

참조로 통합된 문서 (11vac10-180)

Racing Medication and Testing Consortium, Penalty Guidelines, undated.

Uniform Classification Guidelines for Foreign Substances and Recommended Penalties and Model Rule, revised July 2007, Association of Racing Commissioners International, Inc.